Friday, July 10, 2026

Drug profile · INN

ly3484356

ly3484356 is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 0
Pipeline programs 2
News articles 0
Drug details — ly3484356
Class
Route
Patents
0
Programs
2
Data quality
0.70

Quick answer

ly3484356 is an FDA-listed pharmaceutical active ingredient.

Key facts

INN ly3484356

Approval history

Authority Status Date
NMPA clinical trials

Pipeline programs

  1. EMBER: A Study of LY3484356 in Patients with Breast or Other Non-Breast Cancers Phase 1 · Eli Lilly and · Breast Cancer, Endometrial cancer
  2. LY3484356 Phase 1 · Eli Lilly and · Breast Neoplasms

Frequently asked questions

What is ly3484356?

ly3484356 is an FDA-listed pharmaceutical active ingredient.